A recent retrospective cohort study evaluated the duration of antipsychotic (AP) treatment among nursing home residents with dementia, revealing critical insights into the effectiveness of federal policies aimed at reducing AP use. The analysis encompassed 43,668 new episodes of AP initiation among 38,275 residents, focusing on treatment duration and discontinuation rates within six months following the implementation of two key initiatives: the National Partnership to Improve Dementia Care (2012) and the Five Star Rating system (2015).

The findings indicate that the average duration of AP treatment decreased slightly from 125.9 days in the pre-Partnership period to 120.5 days and 120.6 days in the subsequent periods. Notably, residents who initiated APs after these policy changes were significantly more likely to discontinue treatment within six months, with adjusted hazard ratios of 1.17 and 1.19, respectively. Despite these changes, the study highlights that more than half of the residents continued their AP treatment beyond the six-month mark, suggesting that while policies have influenced initiation and discontinuation rates, their overall impact on treatment duration remains limited.

This study underscores the need for a reevaluation of current strategies aimed at managing AP use in dementia care. The findings suggest that while federal initiatives have made strides in reducing the prevalence of AP prescribing, they have not substantially altered the duration of treatment among nursing home residents. This raises important questions about the effectiveness of existing policies and the potential need for more robust interventions to ensure that AP use aligns with best practices in dementia care, ultimately influencing future research and therapeutic approaches in this domain.

Source: academic.oup.com